16-56192353-G-C
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_020988.3(GNAO1):c.118G>C(p.Gly40Arg) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 16/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G40A) has been classified as Pathogenic.
Frequency
Consequence
NM_020988.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020988.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNAO1 | NM_020988.3 | MANE Select | c.118G>C | p.Gly40Arg | missense splice_region | Exon 1 of 9 | NP_066268.1 | ||
| GNAO1 | NM_138736.3 | c.118G>C | p.Gly40Arg | missense splice_region | Exon 1 of 8 | NP_620073.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNAO1 | ENST00000262493.12 | TSL:1 MANE Select | c.118G>C | p.Gly40Arg | missense splice_region | Exon 1 of 9 | ENSP00000262493.6 | ||
| GNAO1 | ENST00000262494.13 | TSL:1 | c.118G>C | p.Gly40Arg | missense splice_region | Exon 1 of 8 | ENSP00000262494.7 | ||
| GNAO1 | ENST00000638705.1 | TSL:1 | c.118G>C | p.Gly40Arg | missense splice_region | Exon 1 of 8 | ENSP00000491223.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 25
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Epileptic encephalopathy Pathogenic:2
de novo variant, previously described in the literature, absent from gnomAD.
not provided Pathogenic:1Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30682224, 31278258, 32581362, 34122306, 33057194, 37541188, 35982159, 31175295, 31785789, 31440721, 37548038, 28357411)
Developmental and epileptic encephalopathy Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. A different variant affecting this nucleotide (c.118G>A)resulting in the same protein affect (p.G40R) has been determined to be pathogenic (PMID: 26485252, 28747448, 28817111). This suggests that this nucleotide is important for normal RNA splicing, and that other variants at this position may also be pathogenic. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant has been reported to be de novo in individuals affected with GNAO1 related disease; however, paternity was not confirmed (PMID: 28357411, Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 40 of the GNAO1 protein (p.Gly40Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant also falls at the last nucleotide of exon 1 of the GNAO1 coding sequence, which is part of the consensus splice site for this exon.
Developmental and epileptic encephalopathy, 17 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at